How the association between obesity and inflammation may lead to insulin resistance and cancer
Background and objectives Obesity is associated with metabolic dysfunction and over
nutrition. Increased body mass index and obesity are strongly amalgamated with changes in …
nutrition. Increased body mass index and obesity are strongly amalgamated with changes in …
[HTML][HTML] Effects of short-term fasting on cancer treatment
S de Groot, H Pijl, JJM van der Hoeven… - Journal of Experimental & …, 2019 - Springer
Growing preclinical evidence shows that short-term fasting (STF) protects from toxicity while
enhancing the efficacy of a variety of chemotherapeutic agents in the treatment of various …
enhancing the efficacy of a variety of chemotherapeutic agents in the treatment of various …
[HTML][HTML] Insulin resistance in patients with acromegaly
G Vila, JOL Jørgensen, A Luger… - Frontiers in endocrinology, 2019 - frontiersin.org
Acromegaly is characterized by chronic overproduction of growth hormone (GH) that leads
to insulin resistance, glucose intolerance and, ultimately, diabetes. The GH-induced …
to insulin resistance, glucose intolerance and, ultimately, diabetes. The GH-induced …
Growth hormone response to oral glucose load: from normal to pathological conditions
M Hage, P Kamenický, P Chanson - Neuroendocrinology, 2019 - karger.com
The exact physiological basis of acute growth hormone (GH) suppression by oral glucose is
not fully understood. Glucose-mediated increase in hypothalamic somatostatin seems to be …
not fully understood. Glucose-mediated increase in hypothalamic somatostatin seems to be …
Pasireotide responsiveness in acromegaly is mainly driven by somatostatin receptor subtype 2 expression
A Muhammad, EC Coopmans, F Gatto… - The Journal of …, 2019 - academic.oup.com
Background The response to first-generation somatostatin receptor ligands (SRLs) treatment
in acromegaly correlates with expression of somatostatin receptor subtype 2 (SSTR2) …
in acromegaly correlates with expression of somatostatin receptor subtype 2 (SSTR2) …
[HTML][HTML] Effects of intermittent fasting during Ramadan on insulin-like growth factor-1, interleukin 2, and lipid profile in healthy Muslims
AR Rahbar, E Safavi, M Rooholamini… - … journal of preventive …, 2019 - journals.lww.com
Background: Due to high content of fructose, honey has been introduced as a suitable
natural sweetener for patients with type 2 diabetes. We investigated the effect of honey …
natural sweetener for patients with type 2 diabetes. We investigated the effect of honey …
[HTML][HTML] Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy
T Brue, A Lindberg, A Jan van der Lely, AC Akerblad… - Endocrine, 2019 - Springer
Purpose To explore the effects of pegvisomant (PEGV) on glucose metabolism in patients
with acromegaly within ACROSTUDY, an international, observational, prospective safety …
with acromegaly within ACROSTUDY, an international, observational, prospective safety …
Insulin resistance and adrenal incidentalomas: a bidirectional relationship
GI Sydney, KJ Ioakim, SA Paschou - Maturitas, 2019 - Elsevier
An adrenal incidentaloma (AI) is an adrenal mass incidentally found via a radiological
modality, independent of an endocrinological investigation. In this review, we aimed to …
modality, independent of an endocrinological investigation. In this review, we aimed to …
Rhythmic growth hormone secretion in physiological and pathological conditions: Lessons from rodent studies
Evolutionally conserved in all mammalians, the release of GH occurs in a rhythmic pattern,
characterized by several dominant surges (pulsatile GH) with tonic low inter-pulse levels …
characterized by several dominant surges (pulsatile GH) with tonic low inter-pulse levels …
Contribution of Liver Fat to Weight Loss–Induced Changes in Serum Hepatokines: A Randomized Controlled Trial
I Telgenkamp, YHAM Kusters… - The Journal of …, 2019 - academic.oup.com
Context Hepatokines have emerged as potential mediators of obesity-associated
comorbidities, such as type 2 diabetes, cardiovascular disease, fractures, and central …
comorbidities, such as type 2 diabetes, cardiovascular disease, fractures, and central …